Newbridge Financial Services Group Inc. Takes $33,000 Position in iShares Biotechnology ETF (NASDAQ:IBB)

Newbridge Financial Services Group Inc. bought a new position in shares of iShares Biotechnology ETF (NASDAQ:IBB) during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor bought 249 shares of the financial services provider’s stock, valued at approximately $33,000.

Several other institutional investors and hedge funds have also bought and sold shares of the stock. BNP Paribas Financial Markets raised its holdings in iShares Biotechnology ETF by 29.3% during the third quarter. BNP Paribas Financial Markets now owns 2,380,229 shares of the financial services provider’s stock worth $346,561,000 after acquiring an additional 538,899 shares in the last quarter. Commerce Bank raised its holdings in iShares Biotechnology ETF by 1.8% during the third quarter. Commerce Bank now owns 743,366 shares of the financial services provider’s stock worth $108,234,000 after acquiring an additional 12,921 shares in the last quarter. Healthcare of Ontario Pension Plan Trust Fund raised its holdings in iShares Biotechnology ETF by 32.9% during the third quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 663,000 shares of the financial services provider’s stock worth $96,533,000 after acquiring an additional 164,000 shares in the last quarter. Main Management ETF Advisors LLC raised its holdings in iShares Biotechnology ETF by 2.5% during the third quarter. Main Management ETF Advisors LLC now owns 593,370 shares of the financial services provider’s stock worth $86,395,000 after acquiring an additional 14,535 shares in the last quarter. Finally, Aprio Wealth Management LLC bought a new stake in iShares Biotechnology ETF during the fourth quarter worth about $18,476,000. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Trading Down 1.4 %

IBB opened at $134.24 on Wednesday. iShares Biotechnology ETF has a 52-week low of $123.60 and a 52-week high of $150.57. The business’s 50-day simple moving average is $135.99 and its 200 day simple moving average is $141.17.

iShares Biotechnology ETF Cuts Dividend

The firm also recently disclosed a dividend, which was paid on Friday, December 20th. Shareholders of record on Tuesday, December 17th were paid a $0.0624 dividend. The ex-dividend date of this dividend was Tuesday, December 17th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.